Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rapid spread of the SARS-CoV-2 JN.1 lineage is associated with increased neutralization evasion
Lu Zhang, Alexandra Dopfer-Jablonka, Anne Cossmann, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109904-109904
Open Access | Times Cited: 12

Showing 12 citing articles:

Neutralization and Stability of JN.1-derived LB.1, KP.2.3, KP.3 and KP.3.1.1 Subvariants
Pei Li, Julia N. Faraone, Cheng Chih Hsu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 7
Humoral immunity after mRNA SARS-CoV-2 omicron JN.1 vaccination
Christine Happle, Markus Hoffmann, Amy Kempf, et al.
The Lancet Infectious Diseases (2024)
Closed Access | Times Cited: 7
Pseudotyped Viruses: A Useful Platform for Pre-Clinical Studies Conducted in a BSL-2 Laboratory Setting
Sofiia N. Rizatdinova, Alina E. Ershova, Irina V. Astrakhantseva
Biomolecules (2025) Vol. 15, Iss. 1, pp. 135-135
Open Access
The KP.2-adapted COVID-19 vaccine improves neutralising activity against the XEC variant
Mehul S. Suthar, Kelly E. Manning, Madison L Ellis, et al.
The Lancet Infectious Diseases (2025)
Closed Access
A shark-derived broadly neutralizing nanobody targeting a highly conserved epitope on the S2 domain of sarbecoviruses
Bo Feng, Cuiyun Li, Zhaoyong Zhang, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Immune Evasion, Cell-Cell Fusion, and Spike Stability of the SARS-CoV-2 XEC Variant: Role of Glycosylation Mutations at the N-terminal Domain
Pei Li, Julia N. Faraone, Cheng Chih Hsu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
A mimetic peptide of ACE2 protects against SARS-CoV-2 infection and decreases pulmonary inflammation related to COVID-19
Ernna Hérida Domingues de Oliveira, Ana C Monteleone-Cassiano, Lucas Tavares, et al.
Antiviral Research (2024) Vol. 229, pp. 105968-105968
Closed Access | Times Cited: 3
SARS-CoV-2 Omicron XBB infections boost cross-variant neutralizing antibodies, potentially explaining the observed delay of the JN.1 wave in some Brazilian regions
Luis Fernando López Tort, Mia Ferreira de Araújo, Ighor Arantes, et al.
IJID Regions (2024) Vol. 14, pp. 100503-100503
Open Access
Humoral Immunity after mRNA Omicron JN.1 Vaccination
Christine Happle, Markus Hoffmann, Amy Kempf, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Into the Cauldron of the Variant Soup: Insights into the Molecular Epidemiology and Transition to Endemicity of SARS-CoV-2 in Cyprus (November 2022–February 2024)
Andreas C. Chrysostomou, Leondios G. Kostrikis
Viruses (2024) Vol. 16, Iss. 11, pp. 1686-1686
Open Access
Comparative Analysis of Host Cell Entry Efficiency and Neutralization Sensitivity of Emerging SARS-CoV-2 Lineages KP.2, KP.2.3, KP.3, and LB.1
Nianzhen Chen, Katharina Decker, Sebastian Schulz, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1236-1236
Open Access
Potent neutralization by a RBD antibody with broad specificity for SARS-CoV-2 JN.1 and other variants
Michael S. Piepenbrink, Ahmed Magdy Khalil, Ana C. Chang, et al.
npj Viruses (2024) Vol. 2, Iss. 1
Open Access
Page 1

Scroll to top